With the accumulation of evidence that Herpesvirus hominis strains from genital sources may differ from oral strains in antigenic and biological properties (2, 5, 9-11), there has been a search for markers which would help to divide isolates into two types. It appeared that plaque production in monolayers of primary chick embryo cells might provide a simple technique for such typing since it has been reported that genital strains plaque in these cells when oral strains do not (4, 8 
With the accumulation of evidence that Herpesvirus hominis strains from genital sources may differ from oral strains in antigenic and biological properties (2, 5, (9) (10) (11) , there has been a search for markers which would help to divide isolates into two types. It appeared that plaque production in monolayers of primary chick embryo cells might provide a simple technique for such typing since it has been reported that genital strains plaque in these cells when oral strains do not (4, 8) . To compare this technique with the results of an antigenic analysis, we tested 100 isolates for their efficiency of plating (EOP) on chick embryo cells versus that on human embryonic fibroblasts and classified 52 of these strains by kinetic neutralization.
There was not complete agreement between the EOP and neutralization, nor between either marker and the source of the strain. It appeared that the two markers vary independently. Se- lection of variants with increased EOP values did not result in an accompanying change in neutralization.
MATERIALS AND METHODS Viruses. The 100 strains of Herpesvirus hominis were isolated between 1967 and 1971; 61 came from diagnostic specimens, 9 of which were isolated in Taiwan and the rest in Seattle, and 39 strains were isolated during a long-term family study, the Seattle Virus Watch (M. K. Cooney, K. S. W. Kim, and J. P. Fox, Bacteriol. Proc., p. 199, 1971 ). The 9 Taiwan strains were kindly supplied by James L. Gale (NAMRU-2, Taipei, Taiwan) and 24 Seattle strains by C. George Ray (Children's Orthopedic Hospital, Seattle, Wash.). Strains were isolated in either diploid or heteroploid human cell lines. They were propagated in human fibroblast cells and were in passages 4 to 9 when tested.
The age and sex distribution of the patients from whom these strains were isolated are shown in Table  1 . All but three of the isolates presumed to have come from genital sources were obtained from lesions of cases diagnosed as herpes progenitalis. An isolate from the lesion of a neonatal infection and two from lesions of the lower back have also been classified as from genital sources (2) . The isolates considered to be from oral sources were obtained from cultures of throats, brain tissue, mouth, or facial lesions. Among 377 Male  11  3  6  2  5  2  29  Female  8  1  15  5  2  0  41  Total  19  4  21  7  7  2  60   Genital  Male  0  1  4  2  1  0  8  Female  1  6  16  3  0  6  32  Total   1  7  20  5  1  6  40 these patients, 2 had encephalitis, 5 had pneumonia, 2 had leukemia, 1 had otitis media, 6 had a diagnosis of pharyngitis, and 11 had lower respiratory disease. Cells and media. Primary chick embryo (CE) cells were obtained from 9-to 11-day-old embryonated eggs. Monolayers were prepared by seeding 60-mm plastic dishes with 2.5 X 106 cells per plate and incubating the plates for 3 to 4 days in 2.5%o CO2 in air at 37 C. The FT line of human embryonic fibroblasts was derived in our laboratory from fetal tonsillar tissue (17) . Both FT and CE cells were grown in Eagle's minimum essential medium (MEM) with 10% fetal calf serum, 6.6 mm sodium bicarbonate, 100 pig of streptomycin per ml, 100 units of penicillin per ml, and 10 units of mycostatin per ml. Viral inocula were diluted in MEM with 2%7 "GG-free" calf serum and antibiotics (MEM2).
Plaque assays. The use of a human fibroblast cell line for plaque assay of herpesvirus strains has been described (17) . Inoculation, incubation, and staining were the same for either FT Guinea pigs were given three intramuscular injections of virus at 9-to 10-day intervals and were bled 9 days after the last injection. The first injection contained 103 to 104 plaque-forming units (PFU) in Freund's incomplete adjuvant. The second injection contained 105 to 106 PFU and the third, 106 to 107 PFU; neither was mixed with adjuvant. Viral inocula were grown in FT cells by using MEM without serum. The supernatant fluids from cultures showing an extensive cytopathic effect were centrifuged and filtered to remove cells.
Neutralization. The sera were tested for K values at 37 C for 10 min, according to the method previously described (17) . The type 1 rabbit antiserum had a homologous K of 10.2 with a standard deviation (SD) of 1.70 and a heterologous K of 3.0 (SD = 1.75) for type 2 strains in the neutralizations required for testing all the viruses. The type 2 rabbit antiserum had a homologous K of 4.7 (SD = 1.62) and a heterologous K of less than one with known type 1 strains (K = 0.7; SD = 0.4).
The type 1 guinea pig antiserum had a homologous K of 39.4 (SD = 7.65) and a heterologous K of 8.9 (SD = 2.77). The type 2 guinea pig antiserum had a homologous K of 10.2 (SD = 3.86), with the type 2 strain, and a heterologous K of 2.4 (SD = 1.29).
The test viruses were compared with the homologous strains in kinetic neutralization tests with these sera. An estimate of antigenic relatedness was calculated from the equation: Ra = (K2/K02)/(K1/Kc1). and for the rabbit sera is -0.580, both of which are significant at P < 0.01. Five of the type 1 strains came from genital lesions and one of the type 2 strains from a throat culture. The 10 strains with inconsistent EOP and R5 values were all from oral sources. It has been reported that EOP on chick cells increased with laboratory passage on rabbit or human cells (8) , which may account for the EOP of these strains, although they were in no higher passages when tested than those with a lesser EOP. The R,, values of these 10 strains varied from 0.08 to 0.39 and, as can be seen from Fig. 1 Patients from whom oral isolates were obtained were not concentrated into such a limited age span and ranged from infancy to 82 years of age. The age distribution was the same for those whose isolates showed inconsistent EOP -Ra patterns as for the others. Three of the patients with oral isolates also had a history of genital lesions; one of these had an isolate with a type 2 EOP and a type 1 Ra, but the other two had isolates with type 1 EOP and Ra values. There was no indication in this series of "intermediate" strains isolated from cases with both oral and genital symptomatology.
DISCUSSION
The examination of these herpesvirus strains suggests, as have the results of other studies (2, 9, 12) , that neutralization divides strains into two rather distinct groups, which also differ in biological characteristics. Whether this antigenic difference is of sufficient magnitude and stability to warrant "type" distinctions is a matter of present controversy (6, 9). Although antigenic character does not appear to vary with EOP in this or another study (8) , or with other markers (12, 13) , there is great diversity in the degree of relatedness between strains within groups. Hampar et al. (6) have suggested that H. hominis strains should be classified into one serological group as a species by the use of 7S antibodies and that late 19S antibodies should be used for determining subtypes within that species. When our data for guinea pig sera are compared with data for rabbit sera, it can be seen that the degree of relatedness between strains was influenced by the sera used for neutralization. The efficacy of the guinea pig sera may be due to a relatively higher concentration of 19S antibody.
Be they types or subtypes, however, present evidence suggests the existence of at least two kinds of herpes simplex viruses with differing antigenic and biological characteristics, one of which is associated predominantly with oral infections and the other with genital ones. In this series, as in others (2, 9, 11) , the majority of the isolates from genital sources had the properties now assigned to type 2 viruses. There were, however, five type 1 genital isolates to be added to those previously reported. Nahmias et al. (11) identified eight type 1 strains among 226 genital isolates, and three of Schneweis' nine genital isolates fit the type 2 designation (9). Other investigators have not reported type 1 strains from genital sources (8, 12) . The weight of evidence at present indicates that type 2 virus is limited to the genital tract and has a venereal mode of transmission, but it appears that at least certain type 1 viruses may also behave like genital strains. The number of strains examined so far is relatively small, since data on only about 500 isolates have been reported (8, 9, 11, 12) , and it is possible that type 1 strains may be more prevalent among genital isolates from other populations. The diversity of strains examined by investigators is limited by the epidemiology of infection in the population under study and the relationships between individuals from whom strains were isolated. The strains from the 61 diagnostic specimens in our study were chosen to represent patients with no known epidemiological relationships, but this does not insure that we, any more than other investigators, have not been examining repeated isolations of the same virus. Some family relationships are represented among the 39 strains from the Virus Watch study. Since 10 families had more than one infected family member, 25 families comprise the population for these strains. These families have no known contact with one another.
When the source of strains is known, EOP on chick cells may serve to screen isolates for types. EOP is a simpler procedure than those required for neutralization, and there appears to be excellent correlation between the EOP and Ra of genital isolates. Lowry et al. (8) tested 40 genital isolates which were type 2 by neutralization and found no discrepancies between the chick cell and neutralization results. Since we did not find the same agreement with oral strains noted by these investigators, neutralization may be needed to clarify the status of oral isolates with type 2 EOP values.
If H. hominis strains are to be classified with some amount of sophistication, markers which vary independently and are suitable for use with a large number of strains will be needed. A difference in deoxyribonucleic acid density between type 1 and type 2 viruses has been reported (5, 7), but this is not a procedure which could readily be used for typing. Other markers which have been investigated include pock production (8, 10) , growth characteristics (4, 8, 14, 15) , thermostability (4, 8, (12) (13) (14) , ultraviolet irradiation (13), cytopathic effect (1, 12, 15) , animal virulence (4, 12) , and sensitivity to inhibitors (8, 14) . Although these tend to show correlation with antigenic typing, in most cases they have been applied to only a few strains used as prototypes. Some of these markers are probably interrelated and could not be expected to vary independently, such as pock production and efficiency of plating on chicken cells, and there is conflicting evidence in regard to some others (1, 4, 8, (12) (13) (14) . Roizman and co-workers (3, 15, 16) have shown that there is considerable variation in the "social behavior" of herpesvirus-infected cells and have suggested that there may be more than two types or that there is a continuum in the range of viral behavior which makes it difficult to identify two distinct types. The lack of correlation between source, EOP, and R5 and the diversity in the EOP and Ra values seen here could be construed as support for this hypothesis. It seems particularly important that a typing scheme should not be based on the study of a limited number of strains by a few investigators. It will require the investigation of a much larger number of strains for several markers which vary independently to determine whether the differences now seen between strains are indicative of two types or whether they represent the extremes of a continuum of variation.
